(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Zanubrutinib
Acalabrutinib
NCCN Guidelines for Patients for CLL
Cancer.gov
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
ASH: COVID-19 Resources for Managing Blood Cancers